The decrease of the molecular size of poly(I C) to less than 106 decreases its ability to induce interferon, protect mice against virus, or enhance the immune response. Immune adjuvant activity appeared more sensitive to molecular weight than the other protective activities. The composition of the complex-the molecular size of the individual homopolymers when one was large and the other small-did not affect antiviral activity; the activity of a complex made from large poly(I) and small poly(C) was similar to one made from small poly(I) and large poly(C). Molecular size of the complex did not profoundly alter the side effects of poly(I-C). At 2 mg/kg, none of the complexes markedly altered phagocytic function. Only the largest complex sensitized the mouse to endotoxin. However, all of the complexes studied profoundly inhibited drug metabolism by the liver microsomal enzymes between 24 and 72 hr after their inoculation. Decreasing the molecular weight did not alter this inhibition.
The double-stranded synthetic polynucleotide, polyriboinosinic-polyribocytidylic acid [poly(IJ C) ], is a potent antiviral agent, interferon inducer (1, 2) , and antitumor agent (3, 4 ; Tarnowski, G. S., Stock, C. C., and Hamilton, L. D., unpublished data). Poly (I-C) also has certain side effects: it is embryotoxic in rabbits and it elevates the concentration of serum transaminases and the prothrombin time in dogs (5) and monkeys (6) . The polynucleotide produces effects similar to endotoxin: it is pyrogenic (5, 7, 8) , may elicit leukopenia (5, 9) , and can provoke the Schwartzman phenomenon (10) .
Variations in lethality in mammals of different preparations of poly(I. C) were first noted, and later, variations in antitumor and antiviral activity were observed (11) . These observations led to a retrospective correlation of biological potency with s2ow distribution of the complexes (11) . A correlation emerged between the increasing s2ow and the median lethel dose (LDso). For the complex with the highest molecular weight distribution, the least amount was required for the LDse; complexes with s20,wt less than [20] [21] [22] [23] [24] [25] seemed the least toxic. The antiviral and antitumor activity seemed parallel, but although the complexes with the lowest molecular weight distribution were the least effective, the complexes that were more toxic (possibly because of their higher sedimentation distribution) were also less effective against the Ridgeway osteogenic sarcoma and foot-and-mouth disease virus. The data, too few to be conclusive, nevertheless suggested that chain lengths above a certain point may be more toxic and less therapeutically efficient against tumors and viruses (11). To explore this likelihood, we made a series of complexes of poly(IJC) using homopolymers of poly(J) and poly(C) with widely differing 820,W distributions, since we had previously established that the 320w0 values in the original homopolymers were important in determining the distribution of s20,w values of the complexes. This paper correlates the molecular weight distribution of poly(I C) complexes with interferon induction, protection of mice against encephalomyocarditis virus, immuno-enhancing activity, sensitization of mice to endotoxin, and inhibition of drug metabolism in vivo and in vitro.
MATERIALS AND METHODS
Preparation of Poly(I. C). Synthetic double-stranded complexes of polyriboinosinic and polyribocytidylic homopolymers were prepared and characterized as described (11) . The distribution of sedimentation coefficients in polynucleotide samples was determined at 117,000 X g in a Spinco model E analytical ultracentrifuge equipped with a photoelectric scanner and UV optics. The polynucleotide sample was made up in Inhibition of Drug Metabolism In Vivo was assessed by inoculation of mice i.v. with poly(J* C) or saline. At intervals thereafter, mice were inoculated i.v. with hexobarbital (80 mg/kg), and the sleeping time was determined for individual mice (10 mice per group) (13) .
Inhibition of Microsomal Mixed Functional Oxidase Enzymes In Vitro was assessed with type I substrate. This procedure evaluates the hydroxylation activity of the liver in the metabolism of foreign compounds. Groups of mice were inoculated with poly(J* C) i.v., and livers were removed from five mice 24 hr later. The 9000 X g liver supernatant fractions from individual livers were reacted with aminopyrine and the necessary cofactors, and the conversion of aminopyrine to formaldehyde was determined (14) .
Evaluation of Data rested on calculation of the means with standard deviations and standard errors and the use of Student's t test for determination of significant differences from control values. For determination of the 50% protective dose of the complexes in vivo against EMC virus, the mortality data were analyzed by probit analysis on a CDC 6600 computer, and the 95% confidence limits for the 50% protective dose was calculated.
RESULTS
Relationship of Interferon Induction to Molecular Size. The mode of the sedimentation distribution of the complexes varied from 8S for the smallest complex to 40S for the largest complex (Fig. 1 ). The ability of these complexes to induce serum interferon decreased with decreasing molecular size, particularly when the comparison was made at a dose of 0.33 mg of complex/kg (Fig. 2 ). Relationship of Antiviral Protection to Molecular Size and Composition. The other protective abilities of the complexes also decreased with decreasing size. For the largest 40S complex, the least amount of polynucleotide was required to protect 50% of the mice from death with EMC virus. The smallest (8S) complex was considerably less protective ( Table 1) (Table 2 ). Immunoenhancement may, thus, be more affected by molecular size than interferon induction or antiviral activity. At doses of 1-2 mg/kg, the 8S complex protected mice against EMC and induced significant amounts of interferon. The series of complexes-25S, 12S, and 11S-also showed decreasing influential. At 24 hr after administration of complex, the sleeping time after the injection of the largest 40S complex was increased 88%, while sleeping time after that of the smallest 8S complex was increased 167%. At 48 hr after administration of the complexes, they also significantly prolonged sleep. This inhibition of drug metabolism disappeared by day 7 after poly(I-C) administration. For example, the poly(I -C) 12S complex prolonged sleeping time from 36.9 min in controls to only 48.0 min.
Metabolism of Aminopyrine. The polynucleotides also inhibited metabolism of aminopyrine by 9000 X g liver supernatant fractions. At 24 hr after polynucleotide administration, the 40S, 8S, and PL-reference complexes inhibited drug metabolism by 33-46% (Table 4 ). The poly(I C) 1iS complex depressed drug metabolism by only 10%. Thus, the poly(IJ C) complexes generally inhibited drug metabolism by liver microsomal enzymes, in vivo and in vitro. Within the molecular size range studied, there was no decrease in this side-effect with decreasing molecular size. DISCUSSION The estimated molecular weights of the poly(I * C) complexes ranged from 0.11-3.1 X 106 for CK22 (8S, equivalent to a molecular weight of 5 X 105) to 0.11-366 X 106 for CK19 (40S, equivalent to a molecular weight of 38.2 X 106) (11) . Over this almost 100-fold range of molecular size, all of the protective activities decreased with decreasing molecular size. However, complexes with a sedimentation rate larger than 10S (molecular weight about 0.9 X 106) were generally all active antiviral agents, immunologic adjuvants, and interferon inducers. The critical molecular size required for high activity appeared to be about 106 for unsubstituted poly(I C) complexes. The 8S complex with a molecular weight less than 106 was markedly less active: its antiviral 50% protective dose was 3.8 times greater than that of the 40S complex. This smallest complex also induced much less interferon, inducing only 7% as much interferon as the 40S complex at the same dosage. The 8S compound was also not an immuno-enhancer, unlike all the other complexes which enhanced the immune response to sheep erythrocyte.
With this series of narrowly characterized poly(I * C) complexes, immune adjuvant activity appears to be the mQst sensitive to decreases in molecular size. These results agree with those of Niblack and McCreary (15) (18) .
The correlation of dose of poly(I. C), serum interferon titer, and ability to protect mice against EMC virus supports the assumption that the poly(I. C) is effective against EMC virus because of its ability to induce interferon; other mechanisms of protection are not excluded. Similarly, the suggestion that at least 100 units of circulating interferon are needed for antiviral activity holds for protection against EMC virus only. Protection against herpes simplex virus in mice has been achieved with both poly(A * U) and poly(I * C), probably by additional protective mechanisms (19) . (3) . A decrease in the molecular size of the polymers did not markedly affect the inhibition of drug metabolism. Thus, this effect on the host's capacity to metabolize foreign compounds must be taken into account in assessment of the clinical usefulness of the polyribonucleotide complexes. Inhibition of drug metabolism could be a serious side effect of poly(J C).
